Bernard Gilly, Ph.D., one of our founders, has served as our Chief Executive Officer since our creation. From our creation through to 2016, Bernard served as Chairman of our Board of Directors.

From 2011 through 2014, he served as Chief Executive Officer at Pixium Vision and from which date he has served as nonexecutive Chairman of the board of directors. In addition, he currently serves on the boards of Prophesee S.A. (formerly Chronocam) and Gecko Biomedical. From 2005 to 2009, he founded and was Chairman and Chief Executive Officer of Fovea Pharmaceuticals S.A., or Fovea, a privately funded biotech company, which was later acquired by Sanofi. He then became Senior Vice President of the Ophthalmology Division of Sanofi and served in that role until March 2012.

Prior to Fovea, Mr. Gilly was a partner at Sofinnova Partners S.A.S. from December 2000 to November 2005. From January 1992 to October 2000, he was Chief Executive Officer of Transgene S.A., a company listed on the Nasdaq and the Nouveau Marche of Euronext Paris, France. Mr. Gilly received an engineering degree from Ecole Nationale d’Agronomie and a Ph.D. from Universite de Rennes.